Related Experiment Video
Updated: May 25, 2026

Double-barreled and Concentric Microelectrodes for Measurement of Extracellular Ion Signals in Brain Tissue
Published on: September 5, 2015
Two dyad-free Shaker-type K⁺ channel blockers from scorpion venom
1Group of Animal Innate Immunity, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, 1 Beichen West Road, Chaoyang District, Beijing 100101, China.
Abstract:
Most of scorpion toxins affecting voltage-gated K⁺ channels (KTxs) contain a functional dyad composed of a lysine and an aromatic amino acid separated by a suitable distance. By means of two-electrode voltage clamp technique, we describe functional characterization of two Mesobuthus martensii KTxs (BmP02 and BmP03) without the dyad. These two toxins differ by only one single residue at site 16 (K16N) but they display differential affinities on insect and mammalian Shaker-type K⁺ channels expressed in Xenopus oocytes. At 1 μM concentration, BmP02 and BmP03 inhibited currents of rK(v)1.1, rK(v)1.2, rK(v)1.3, and Shaker IR, but lacked detectable activity on rK(v)1.4. The half-inhibitory concentrations (IC₅₀) of BmP02 for rK(v)1.1, rK(v)1.2, rK(v)1.3 and Shaker IR channels are 1.95 μM, 4.40 μM, 7 nM and 20.44 μM, respectively. For BmP03, the corresponding IC₅₀ values for these channels are 5.48 μM, 530 nM, 85.4 nM, and 4.64 μM, respectively. Affinity variation (more than 10-fold) between BmP02 and BmP03 on rK(v)1.3 indicates functional importance of a cationic side chain at site 16. A pH-dependent experiment and a double mutant cycle analysis suggest that the residue K16 resides on the channel-facing surface of the toxin and within 5 Å of rK(v)1.3 position 401. These two toxins block rK(v)1.3 in a weak voltage-dependent manner and both slightly shift the current activation curve to positive potentials. Our work is thus crucial to further understanding structure-function relationship of KTxs without a functional dyad.
Related Concept Videos
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

